Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment

Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its Enzalutamide Tablets, available in 40 mg and ... Read More